Tsutomu Kodera

810 total citations
20 papers, 535 citations indexed

About

Tsutomu Kodera is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Tsutomu Kodera has authored 20 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Tsutomu Kodera's work include Pancreatic function and diabetes (6 papers), Cancer-related Molecular Pathways (4 papers) and Cancer therapeutics and mechanisms (3 papers). Tsutomu Kodera is often cited by papers focused on Pancreatic function and diabetes (6 papers), Cancer-related Molecular Pathways (4 papers) and Cancer therapeutics and mechanisms (3 papers). Tsutomu Kodera collaborates with scholars based in Japan, Italy and United States. Tsutomu Kodera's co-authors include Satoko Yamada, Itaru Kojima, Akemi Hara, Manabu Kitagaki, Hirofumi Obinata, Toshimitsu Ito, Kaku Tamura, Kazuyasu Miyoshi, Kazuo Imai and Mayu Ikeda and has published in prestigious journals such as Endocrinology, Journal of Medicinal Chemistry and The Lancet Infectious Diseases.

In The Last Decade

Tsutomu Kodera

20 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsutomu Kodera Japan 13 182 172 145 89 88 20 535
Monika Lamba Saini India 12 269 1.5× 261 1.5× 56 0.4× 22 0.2× 39 0.4× 32 668
Ming Shi China 10 199 1.1× 140 0.8× 194 1.3× 39 0.4× 105 1.2× 22 551
Yarong Song China 17 519 2.9× 242 1.4× 133 0.9× 74 0.8× 25 0.3× 42 1.1k
Juliane Hoffmann Germany 16 559 3.1× 192 1.1× 98 0.7× 28 0.3× 30 0.3× 26 1.1k
Jordi Curto Spain 15 553 3.0× 185 1.1× 149 1.0× 34 0.4× 10 0.1× 34 1.0k
Aylin Köseler Türkiye 13 114 0.6× 49 0.3× 166 1.1× 44 0.5× 74 0.8× 42 499
Likun Zhuang China 17 545 3.0× 70 0.4× 211 1.5× 18 0.2× 93 1.1× 38 973
Tom Kim United States 5 153 0.8× 72 0.4× 194 1.3× 36 0.4× 26 0.3× 8 463
Yongjun Guan China 14 364 2.0× 250 1.5× 243 1.7× 36 0.4× 115 1.3× 34 871

Countries citing papers authored by Tsutomu Kodera

Since Specialization
Citations

This map shows the geographic impact of Tsutomu Kodera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsutomu Kodera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsutomu Kodera more than expected).

Fields of papers citing papers by Tsutomu Kodera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsutomu Kodera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsutomu Kodera. The network helps show where Tsutomu Kodera may publish in the future.

Co-authorship network of co-authors of Tsutomu Kodera

This figure shows the co-authorship network connecting the top 25 collaborators of Tsutomu Kodera. A scholar is included among the top collaborators of Tsutomu Kodera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsutomu Kodera. Tsutomu Kodera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kadoya, Masato, et al.. (2022). Involuntary Movements During Treatment for Hyperglycemia. AACE Clinical Case Reports. 9(1). 21–22. 3 indexed citations
2.
Tabata, Sakiko, Kazuo Imai, Shuichi Kawano, et al.. (2020). Non-Severe vs Severe Symptomatic COVID-19: 104 Cases from the Outbreak on the Cruise Ship 'Diamond Princess' in Japan. SSRN Electronic Journal. 11 indexed citations
3.
Tabata, Sakiko, Kazuo Imai, Shuichi Kawano, et al.. (2020). Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis. The Lancet Infectious Diseases. 20(9). 1043–1050. 170 indexed citations
5.
Gakuhari, Takashi, Yoshiyuki Araki, Tsutomu Kodera, et al.. (2016). Trial application of oxygen and carbon isotope analysis in tooth enamel for identification of past-war victims for discriminating between Japanese and US soldiers. Forensic Science International. 261. 166.e1–166.e5. 13 indexed citations
6.
Saito, Rie, Satoko Yamada, Yoritsuna Yamamoto, et al.. (2011). Conophylline Suppresses Pancreatic Stellate Cells and Improves Islet Fibrosis in Goto-Kakizaki Rats. Endocrinology. 153(2). 621–630. 42 indexed citations
7.
Shimomura, Toshiyasu, Yoko Nakatsuru, Takashi Mita, et al.. (2010). MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel. Molecular Cancer Therapeutics. 9(1). 157–166. 100 indexed citations
8.
Kojima, Ikuho, Izumi Takei, Kazuo Umezawa, et al.. (2010). Rac1 regulates glucose-induced insulin secretion through the modulation of cytoskeletal organization in beta cells. Endocrine Journal. 57. 386. 1 indexed citations
9.
Yamada, Satoko, et al.. (2010). Extracellular matrix modulates insulin production during differentiation of AR42J cells: Functional role of Pax6 transcription factor. Journal of Cellular Biochemistry. 112(1). 318–329. 10 indexed citations
10.
Hirai, Hiroshi, Toshiyasu Shimomura, Kazuhiro Fukasawa, et al.. (2010). Potent anti-tumor activity of a macrocycle-quinoxalinone class pan-Cdk inhibitor in vitro and in vivo. Investigational New Drugs. 29(4). 534–543. 14 indexed citations
11.
Hirai, Hiroshi, Toshiyasu Shimomura, Makiko Kobayashi, et al.. (2010). Biological characterization of 2-aminothiazole-derived Cdk4/6 selective inhibitor in vitro and in vivo. Cell Cycle. 9(8). 1590–1600. 12 indexed citations
12.
Kodera, Tsutomu, Satoko Yamada, Yoritsuna Yamamoto, et al.. (2009). Administration of Conophylline and Betacellulin-δ4 Increases the β-cell Mass in Neonatal Streptozotocin-treated Rats. Endocrine Journal. 56(6). 799–806. 12 indexed citations
13.
Yamamoto, Yoritsuna, Satoko Yamada, Tsutomu Kodera, et al.. (2008). Reversal of streptozotocin-induced hyperglycemia by continuous supply of betacellulin in mice. Growth Factors. 26(4). 173–179. 7 indexed citations
14.
Nagamine, Masanori, Aihide Yoshino, Motoyasu Ishii, et al.. (2008). Lithium‐induced Hashimoto’s encephalopathy: a case report. Bipolar Disorders. 10(7). 846–848. 14 indexed citations
15.
Yamada, Satoko, Yoritsuna Yamamoto, Masahiro Nagasawa, et al.. (2006). In Vitro Transdifferentiation of Mature Hepatocytes into Insulin-Producing Cells. Endocrine Journal. 53(6). 789–795. 28 indexed citations
16.
Ciomei, Marina, Valter Croci, Enrico Pesenti, et al.. (2004). Antitumor efficacy of edotecarin in combination with other cytotoxic drugs.. 64. 483–483. 1 indexed citations
17.
Morita, Masashi, et al.. (1999). In vivo Anti‐tumor Activity of a Novel Indolocarbazole Compound, J‐107088, on Murine and Human Tumors Transplanted into Mice. Japanese Journal of Cancer Research. 90(10). 1163–1170. 33 indexed citations
18.
Satoh, Toshihiko, Hiroharu Arakawa, Ikuko Suzuki‐Takahashi, et al.. (1998). J-104,871, a Novel Farnesyltransferase Inhibitor, Blocks Ras Farnesylation In Vivo in a Farnesyl Pyrophosphate-Competitive Manner. Molecular Pharmacology. 54(1). 1–7. 31 indexed citations
19.
Aoyama, Tetsuya, Toshihiko Satoh, Katsumasa Nonoshita, et al.. (1998). A New Class of Highly Potent Farnesyl Diphosphate-Competitive Inhibitors of Farnesyltransferase. Journal of Medicinal Chemistry. 41(2). 143–147. 16 indexed citations
20.
Kabuto, Masanori, Takeshi Kubota, Hironao Kobayashi, et al.. (1995). [Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].. PubMed. 47(10). 969–73. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026